Retail News Breaks Archives
Total Store Expo session to address Rx supply chain law
July 8th, 2014
ARLINGTON, Va. – Next month's National Association of Chain Drug Stores Total Store Expo will offer attendees an opportunity to learn directly from the Food and Drug Administration about the implications of the Drug Supply Chain Security Act of 2014.
NACDS said Tuesday that Dr. Ilisa Bernstein, deputy director of the Office of Compliance at the FDA Center for Drug Evaluation and Research (CDER), will hold a presentation on the implementation of the law at the Total Store Expo, which will run Aug. 23 to 26 at the Boston Convention & Exhibition Center.
Bernstein will speak on Sunday, Aug. 24, at 10 a.m. during the Insight Session "Drug Supply Chain Security Act: Overview and Implementation."
As 2015 approaches, manufacturers, distributors and supply chain partners are readying for new phases of implementation of the law, NACDS noted. Bernstein's session will provide clarity to the many deadlines, definitions and intricacies associated with the implementation process of the new law for pharmacies, manufacturers, distributors and supply chain partners, the association said.
"Dr. Bernstein's presentation at the NACDS Total Store Expo is not only timely, but also demonstrates the depth and breadth of what this trade show provides for NACDS members and the industry," NACDS president and chief executive officer Steve Anderson said in a statement. "NACDS has made it a top priority to continue to advocate and to present education opportunities related to the new supply chain law's implementation. The NACDS Total Store Expo presents an ideal opportunity to help deliver on that objective."